Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7623

1.

Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands.

Portevin D, Pflüger V, Otieno P, Brunisholz R, Vogel G, Daubenberger C.

BMC Biotechnol. 2015 Apr 11;15(1):24. [Epub ahead of print]

PMID:
25887592
2.

Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.

Latta CH, Sudduth TL, Weekman EM, Brothers HM, Abner EL, Popa GJ, Mendenhall MD, Gonzalez-Oregon F, Braun K, Wilcock DM.

J Neuroinflammation. 2015 Mar 4;12(1):41.

PMID:
25885682
3.

Super-Resolution Microscopy of Cerebrospinal Fluid Biomarkers as a Tool for Alzheimer's Disease Diagnostics.

Zhang WI, Antonios G, Rabano A, Bayer TA, Schneider A, Rizzoli SO.

J Alzheimers Dis. 2015 Apr 16. [Epub ahead of print]

PMID:
25881910
4.

Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment.

Kandel BM, Avants BB, Gee JC, Arnold SE, Wolk DA.

J Alzheimers Dis. 2015 Apr 16. [Epub ahead of print]

PMID:
25881908
5.

PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases.

Martire S, Mosca L, D M.

Mech Ageing Dev. 2015 Apr 13. pii: S0047-6374(15)00038-X. doi: 10.1016/j.mad.2015.04.001. [Epub ahead of print] Review.

PMID:
25881554
6.

Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.

Song L, Lu SX, Ouyang X, Melchor J, Lee J, Terracina G, Wang X, Hyde L, Hess JF, Parker EM, Zhang L.

Mol Neurodegener. 2015 Mar 26;10(1):14. doi: 10.1186/s13024-015-0011-1.

7.

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.

Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ.

BMC Neurol. 2015 Apr 1;15(1):51. doi: 10.1186/s12883-015-0298-0.

8.

Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.

Coart E, Barrado LG, Duits FH, Scheltens P, van der Flier WM, Teunissen CE, van der Vies SM, Burzykowski T.

J Alzheimers Dis. 2015 Apr 13. [Epub ahead of print]

PMID:
25869788
9.

Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data.

Kong D, Giovanello KS, Wang Y, Lin W, Lee E, Fan Y, Doraiswamy PM, Zhu H.

J Alzheimers Dis. 2015 Apr 13. [Epub ahead of print]

PMID:
25869783
10.

Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid.

Le Bastard N, De Deyn PP, Engelborghs S.

Clin Chem. 2015 Apr 13. pii: clinchem.2014.236679. [Epub ahead of print]

PMID:
25869575
11.

Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus.

Elobeid A, Laurell K, Cesarini KG, Alafuzoff I.

J Neuropathol Exp Neurol. 2015 May;74(5):470-9. doi: 10.1097/NEN.0000000000000191.

PMID:
25868149
12.

Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.

Alcolea D, Vilaplana E, Pegueroles J, Montal V, Sánchez-Juan P, González-Suárez A, Pozueta A, Rodríguez-Rodríguez E, Bartrés-Faz D, Vidal-Piñeiro D, González-Ortiz S, Medrano S, Carmona-Iragui M, Sánchez-Saudinós M, Sala I, Anton-Aguirre S, Sampedro F, Morenas-Rodríguez E, Clarimón J, Blesa R, Lleó A, Fortea J.

Neurobiol Aging. 2015 Mar 9. pii: S0197-4580(15)00162-1. doi: 10.1016/j.neurobiolaging.2015.03.001. [Epub ahead of print]

PMID:
25865441
13.

Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease.

Peng M, Jia J, Qin W.

Neurosci Lett. 2015 Apr 9. pii: S0304-3940(15)00295-5. doi: 10.1016/j.neulet.2015.04.014. [Epub ahead of print]

PMID:
25864780
14.

Biochemical and Neuroimaging Studies in Subjective Cognitive Decline: Progress and Perspectives.

Sun Y, Yang FC, Lin CP, Han Y.

CNS Neurosci Ther. 2015 Apr 13. doi: 10.1111/cns.12395. [Epub ahead of print]

PMID:
25864576
15.

Acute amnestic encephalopathy in amyloid-β oligomer-injected mice is due to their widespread diffusion in vivo.

Epelbaum S, Youssef I, Lacor PN, Chaurand P, Duplus E, Brugg B, Duyckaerts C, Delatour B.

Neurobiol Aging. 2015 Mar 16. pii: S0197-4580(15)00166-9. doi: 10.1016/j.neurobiolaging.2015.03.005. [Epub ahead of print]

PMID:
25862419
16.

Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.

Matías-Guiu JA, Cabrera-Martín MN, Moreno-Ramos T, Valles-Salgado M, Fernandez-Matarrubia M, Carreras JL, Matías-Guiu J.

J Neurol. 2015 Apr 11. [Epub ahead of print]

PMID:
25860346
17.

Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort.

Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, Martins RN; AIBL Research Group.

Alzheimers Res Ther. 2015 Feb 20;7(1):16. doi: 10.1186/s13195-015-0105-6. eCollection 2015.

18.

Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.

Wood PL, Barnette BL, Kaye JA, Quinn JF, Woltjer RL.

Acta Neuropsychiatr. 2015 Apr 10:1-9. [Epub ahead of print]

PMID:
25858158
19.

Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology?

Creegan R, Hunt W, McManus A, Rainey-Smith SR.

Br J Nutr. 2015 Apr 10:1-19. [Epub ahead of print]

PMID:
25857433
20.

A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.

Park SA, Kang JH, Kang ES, Ki CS, Roh JH, Youn YC, Kim SY, Kim SY.

J Clin Neurol. 2015 Apr;11(2):132-41. doi: 10.3988/jcn.2015.11.2.132. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk